Therefore, this study was designed to confirm the molecular defects of hypercholesterolemia in pediatric patients using whole-exome sequencing (WES) rather than gene panels of FH, basing on a single-center group of children and adolescents. The gene discussed is FH; the disease is Hypercholesterolemia.